Science

Ebola Doctors Are Divided on IV Therapy in Africa

NEW YORK TIMES  by Donald G. McNeil, Jr.                                                     Jan. 1, 2015

Medical experts seeking to stem the Ebola epidemic are sharply divided over whether most patients in West Africa should, or can, be given intravenous hydration, a therapy that is standard in developed countries. Some argue that more aggressive treatment with IV fluids is medically possible and a moral obligation. But others counsel caution, saying that pushing too hard would put overworked doctors and nurses in danger and that the treatment, if given carelessly, could even kill patients.

A nurse gave an Ebola patient intravenous fluids at the Red Cross treatment center in Kenema, Sierra Leone, in November. Credit Francisco Leong/Agence France-Presse — Getty Images

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Opinion: How Next Generation Technology Can Stop Ebola Today And Future Pandemics Tomorrow

FORBES   by Anita Goel (chairman and CEO of the Nanobiosym Research Institute and Nanobiosym Diagnostics.)                Dec. 30, 2014

Today, even the world’s best hospitals rely upon a thermometer, a 400-year old technology, to decide who to quarantine for Ebola. The ambiguity in our current approaches to diagnosing Ebola has resulted in over 1400 Ebola suspects in the U.S. today who still have not received a definitive diagnosis.

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Is Ebola Here to Stay?

SCIENTIFIC AMERICAN by Dina Fine Maron                                  Dec. 29, 2014
Kisses are at a premium in the capital of Liberia. Even a hug or a handshake between friends is often out of the question. That’s the new normal ever since Ebola began ravaging communities throughout Liberia, Sierra Leone and Guinea. For much of the past year, residents of these west African countries have wondered if daily life will ever be able to return to the way things once were.

Monrovia, Liberia - November 2014: Ebola survivor Korlia Bonarwolo leads a training of health workers at a mock Ebola Treatment Unit in Liberia. "I think with the knowledge we have now, the treatment is going to be much greater," he says.

Photo: Morgana Wingard/Sarah Grile, 2014

And at the heart of the matter is a scientific question: has Ebola now found a permanent foothold among humans?

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Ebola experts seek to expand testing

A major problem is that relatively few laboratories in West Africa have the necessary equipment and personnel to test blood samples from people thought to have Ebola (see ‘Delayed diagnoses’). But that could soon change. Experts are gathering in Geneva, Switzerland, on 12 December to work out which diagnostic tools could be used wherever Ebola strikes.

Problem, Solution, SitRep, or ?: 

Experts call for faster mobilisation of “overlooked” survivors to contain Ebola epidemic

OXFORD UNIVERSITY PRESS                                                                                  Dec, 10, 2014

In an editorial published online today in the International Journal of Epidemiology, experts from the Departments of Psychiatry and Epidemiology at Columbia University, New York, are calling for survivors of the Ebola epidemic to be mobilised in a bid to hasten containment of the disease.

We already know that the current Ebola outbreak is unique in its magnitude and for its dispersion in dense, mobile populations. Physicians and nurses face high mortality, and foreign aid in the form of medical supplies and staff continues to be unequal to the scope of the problem. With a case recovery rate of around 30% at the present time in West Africa, survivors already number in the thousands.

Problem, Solution, SitRep, or ?: 

WHO: malaria gains 'at risk' in Ebola-affected countries

MEDICAL NEWS TODAY                                                                                                 Dec. 9, 2014

LONDON --Thanks to increased disease control, global deaths to malaria have fallen dramatically, and the number of new cases is steadily declining, say the World Health Organization in a new report. Also, an increasing number of countries are moving toward eliminating the mosquito-borne disease altogether. But the UN agency warns these gains are fragile, and no more so than in countries worse-affected by the Ebola crisis.

 
A new report from the World Health Organization says the number of lives claimed by malaria worldwide fell by 47% between 2000 and 2013, and by 54% in Africa, where the vast majority of deaths occur.

The 2014 World Health Organization (WHO) report says deaths to malaria worldwide fell by 47% between 2000 and 2013. In the WHO African Region, where 90% of deaths to malaria occur, the reduction is 54%.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Rapid Ebola test is focus of NIH grant to Rutgers scientist

REPORTS Of RESEARCH ON TWO METHODS OF RAPID TESTING FOR EBOLA

(Two items, scroll down)

MEDICAL PRESS                                                                                     Dec. 8, 2014

Rutgers researcher David Alland, working with the California biotechnology company Cepheid, has received a grant of nearly $640,000 from the National Institutes of Health to develop a rapid test to diagnose Ebola as well as other viruses that can cause symptoms similar to Ebola.

Researchers will adapt this cartridge, now used worldwide for tuberculosis screenings, to collect and test samples from potential Ebola patients. Credit: John Emerson

Alland, a professor of medicine and associate dean for clinical research at Rutgers New Jersey Medical School and the principal investigator of the project, says would be able to take the test to small villages and other remote locations where the spread of Ebola has been especially rampant and diagnose patients where they live...

Meeting / Event Tags: 
Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

To halt Ebola's spread, researchers race for data

DISCOVER MAGAZINE    By Kari Lydersen                                                                              Dec. 2, 2014
.....redicting the trajectory of Ebola rather than playing catching-up could do much to help prevent and contain the disease. Some experts have called for prioritizing mobile treatment units that can be quickly relocated to the spots most needed. Figuring out where Ebola is likely to strike next or finding emerging hot spots early on would be key to the placement of these treatment centers.

But such modeling requires data, and lots of it.  And for stressed healthcare workers on the ground and government and non-profit agencies scrambling to combat a raging epidemic, collecting and disseminating data is often not a high priority.

Problem, Solution, SitRep, or ?: 

Gates Foundation, other donors launch study of Ebola drugs, survivors' blood, in Africa

ASSOCIATED PRESS                                                                                                  Nov. 18, 2014

A coalition of companies and aid groups announced plans Tuesday to test experimental drugs and collect blood plasma from Ebola survivors to treat new victims of the disease in West Africa.

This Nov. 7, 2014, photo shows the inside a mobile donation unit at the Raleigh-Durham International Airport in Raleigh, N.C. The unit was headed to Africa for use in a study of blood plasma treatment for Ebola patients. (AP Photo/Trevor Jenkins) (The Associated Press)

Plasma from survivors contains antibodies, substances the immune system makes to fight the virus. Several Ebola patients have received survivor plasma and recovered, but doctors say there is no way to know whether it really helps without a study like the one they are about to start within a month.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Cepheid receives grant to develop Ebola diagnostic test

REUTERS                                                           Nov. 20,2014

Molecular diagnostics company Cepheid said it received a grant of up to $3.3 million, co-financed by the Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation, to develop a diagnostic test for the deadly Ebola virus.

The Xpert Ebola test, which is expected to use saliva or a drop of blood to identify the virus, is likely to be offered on an emergency use only basis, Cepheid said on Thursday.

Cepheid and the Gates Foundation are also evaluating deploying the company's RemoteXpert cloud-based monitoring software to help track the spread of the disease.

The U.S. Food and Drug Administration last month granted emergency authorization to two new Ebola diagnostic tests made by BioFire, a subsidiary of medical diagnostics maker BioMerieux.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Science
howdy folks